Ligand validation:5PA2

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 5PA2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5PA2_SAH_A_304	100%	39%	0.051	0.992	0.86	1.51	-	4	0	0	100%	1
5PA0_SAH_A_301	100%	32%	0.043	0.994	1.11	1.59	2	3	1	0	100%	1
5P9P_SAH_A_304	100%	46%	0.043	0.992	0.96	1.12	-	2	1	0	100%	1
5P9O_SAH_A_302	100%	30%	0.044	0.991	1.38	1.42	3	4	0	0	100%	1
5PA1_SAH_A_307	99%	49%	0.052	0.99	0.7	1.24	-	2	1	0	100%	1
5PA6_SAH_A_301	99%	40%	0.048	0.985	0.97	1.37	1	2	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
6I73_SAH_A_401	100%	49%	0.028	0.992	0.78	1.16	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.